Investors
SoliVana Research Institute is building the data layer and clinical brand for nervous-system optimization at scale.
Investment Thesis
- Nervous system optimization is an emerging, defensible category with no incumbent leader.
- Protocol NSR-2026 generates proprietary, longitudinal biometric data with commercial applications.
- AI-guided personalization creates a scalable path from clinical pilot to consumer product.
- Tight integration with SoliVana Wellness Spa provides a real-world patient acquisition channel.
Market Opportunity
The convergence of wearable data, AI, and consumer demand for measurable wellness has created a window for a research-first brand to own the nervous-system optimization category.
SoliVana is positioned as both a clinical research engine and a future product platform — starting with high-ticket protocols and expanding into memberships, digital therapeutics, and licensed IP.
Advisory Board
Dr. Elena Voss
Scientific Advisor
Former principal investigator in autonomic neuroscience at a leading academic medical center.
Marcus Chen
Technology Advisor
AI infrastructure leader with two exits in health-tech data platforms.
Dr. Sarah Okonkwo
Clinical Advisor
Board-certified in lifestyle medicine; former medical director of a functional-medicine clinic.
Request the Investor Deck
We are actively engaging with aligned investors, family offices, and strategic partners. Request the pitch deck and a conversation with Natasha Berness.